CLOV vs LYEL · rev $1.37B vs rev $61.0K
Clover Health Investments Corp (CLOV) versus Lyell Immunopharma Inc (LYEL) — a side-by-side from cached financials, not a winner call.
Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.
Lyell Immunopharma Inc (LYEL) is a biotechnology company listed on US.
Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.
Latest reported LYEL revenue for 2024-12-31 was $61.0K. Net income was -$343.0M. Revenue was down 53.1% from 2023-12-31 to 2024-12-31. LYEL currently screens at market cap $143.5M.
CLOV currently screens at market cap $1.55B. LYEL currently screens at market cap $143.5M.
Not investment advice. Open the CLOV and LYEL stock pages for the full models.
Not investment advice.